세계의 풍선판막성형술 디바이스 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Balloon Valvuloplasty Devices Market is presumed to reach the market size of nearly USD 4.75 Billion by 2032 from USD 2.97 Billion in 2023 with a CAGR of 5.36% under the study period 2024-2032.

Balloon valvuloplasty devices are medical tools used to treat stenotic heart valves, typically in procedures to widen narrowed heart valves, such as the aortic or mitral valves. The process entails threading a catheter with an attached balloon through the blood vessels to the affected valve. Once in place, the balloon is inflated to enlarge the valve opening, improving blood flow and reducing symptoms. Balloon valvuloplasty is a minimally invasive alternative to valve replacement surgery, offering shorter recovery times and reduced risks for certain patients. It is commonly used in pediatric cardiology and for patients not candidates for open-heart surgery.

MARKET DYNAMICS

The balloon valvuloplasty devices market is driven by the increasing prevalence of valvular heart diseases, such as aortic stenosis and mitral regurgitation, due to aging populations and the escalating incidence of cardiovascular risk factors, drives market demand for minimally invasive treatment options like balloon valvuloplasty. This growing disease burden underscores the need for effective & less invasive alternatives to surgical interventions, fuelling market growth. Technological advancements in balloon valvuloplasty devices, including the development of next-generation catheters and delivery systems, enhance procedural success rates and patient outcomes, driving adoption across a wider range of clinical settings. Expanding indications for balloon valvuloplasty beyond traditional high-risk surgical patients to include lower-risk and elderly populations further broadens the market's scope and potential. Moreover, increasing healthcare expenditure and investments in cardiovascular care infrastructure, particularly in emerging economies, contribute to market growth by expanding access to advanced treatment modalities like balloon valvuloplasty. Furthermore, supportive reimbursement policies and regulatory frameworks aimed at facilitating market access and ensuring patient safety and quality of care stimulate market demand for balloon valvuloplasty devices. However, potential complications and the high cost of the procedure may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Balloon Valvuloplasty Devices. The growth and trends of Balloon Valvuloplasty Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Balloon Valvuloplasty Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Standard Balloon
• Cutting Balloon
• Scoring Balloon
• High-Pressure Balloon
• Low-Pressure Balloon

By Application

• Aortic Valve Stenosis
• Pulmonary Valve Stenosis

By Age Group

• Pediatric
• Adult

By End-use

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics
• Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Balloon Valvuloplasty Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Balloon Valvuloplasty Devices market include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, Company, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Innomed Medical Development Ltd., Jotech GmbH, Medtronic Plc, Microport Scientific Corporation, Numed Canada Inc., NuMED Inc., Osypka Medical GmbH, Teleflex Incorporated. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BALLOON VALVULOPLASTY DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Age Group
  • 3.7.4 Market Attractiveness Analysis By End-use
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Standard Balloon Historic and Forecast Sales By Regions
• 5.4. Cutting Balloon Historic and Forecast Sales By Regions
• 5.5. Scoring Balloon Historic and Forecast Sales By Regions
• 5.6. High-Pressure Balloon Historic and Forecast Sales By Regions
• 5.7. Low-Pressure Balloon Historic and Forecast Sales By Regions

6. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Aortic Valve Stenosis Historic and Forecast Sales By Regions
• 6.4. Pulmonary Valve Stenosis Historic and Forecast Sales By Regions

7. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY AGE GROUP

• 7.1. Overview By Age Group
• 7.2. Historical and Forecast Data Analysis By Age Group
• 7.3. Pediatric Historic and Forecast Sales By Regions
• 7.4. Adult Historic and Forecast Sales By Regions

8. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-use
• 8.2. Historical and Forecast Data Analysis By End-use
• 8.3. Hospitals Historic and Forecast Sales By Regions
• 8.4. Ambulatory Surgical Centres Historic and Forecast Sales By Regions
• 8.5. Specialty Clinics Historic and Forecast Sales By Regions
• 8.6. Other Historic and Forecast Sales By Regions

9. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BALLOON VALVULOPLASTY DEVICES COMPANIES

• 10.1. Balloon Valvuloplasty Devices Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF BALLOON VALVULOPLASTY DEVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Abbott Laboratories
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. B. Braun Melsungen AG
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Becton, Dickinson Company
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. NuMED Inc.
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Osypka Medical GmbH
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Boston Scientific Corporation
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Cardinal Health Inc.
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Cook Medical Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Edwards Lifesciences Corporation
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Innomed Medical Development Ltd.
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Jotech GmbH
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Medtronic Plc
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. Microport Scientific Corporation
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Numed Canada Inc.
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Teleflex Incorporated
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies